XRP2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Silence Therapeutics PLC

Watchlist Manager

Watchlist

Price: 12.5 EUR 9.65%

Market Cap: €583.3m

	Silence Therapeutics PLC F:XRP2	UK

Profitability Summary

Silence Therapeutics PLC's profitability score is 34/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

52% > 86%

Negative Operating Margin

-12 497%

Negative 3Y Average Operating Margin

-3 359%

Declining Operating Margin

-168% > -12 497%

Negative Net Margin

-11 139%

Negative 3Y Average Net Margin

-3 176%

Declining Net Margin

-145% > -11 139%

Exceptional Free Cash Flow Margin

2 019%

Strong 3Y Average Free Cash Flow Margin

509%

Free Cash Flow Margin is Increasing

43% > 2 019%

Negative ROE

-88%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-218%

ROIC is Increasing

-134% > -101%

View All

Hide

Collapse

34 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.